These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2801125)
1. [Surface charged liposomes as drug carriers and in vivo tests of mice infected with toxoplasma]. Hou XP; Tao F; Yi YY; Wang WL Yao Xue Xue Bao; 1989 Jan; 24(1):53-7. PubMed ID: 2801125 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations. Seah SK J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347 [TBL] [Abstract][Full Text] [Related]
3. Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes. Tachibana H; Yoshihara E; Kaneda Y; Nakae T J Parasitol; 1990 Jun; 76(3):352-5. PubMed ID: 2352064 [TBL] [Abstract][Full Text] [Related]
4. Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye. Benita S; Plenecassagne JD; Cavé G; Drouin D; Le Hao Dong P; Sincholle D J Microencapsul; 1984; 1(3):203-16. PubMed ID: 6336525 [TBL] [Abstract][Full Text] [Related]
5. Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis. Khalil RM; Murad FE; Yehia SA; El-Ridy MS; Salama HA Pharmazie; 1996 Mar; 51(3):182-4. PubMed ID: 8900871 [TBL] [Abstract][Full Text] [Related]
6. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis. Aguirre-Cruz L; Velasco O; Sotelo J J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648 [TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice]. Xiang X; Ke OY; Zhang Z Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016 [TBL] [Abstract][Full Text] [Related]
9. Lack of therapeutic effect of colchicine on murine toxoplasmosis. Aguirre-Cruz L; Sotelo J J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356 [TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine. Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes. Peer D; Margalit R Arch Biochem Biophys; 2000 Nov; 383(2):185-90. PubMed ID: 11185552 [TBL] [Abstract][Full Text] [Related]
12. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573 [TBL] [Abstract][Full Text] [Related]
13. Effects of pyrimethamine and sulfadiazine on the intestinal development of Toxoplasma gondii in cats. Sheffield HG; Melton ML Am J Trop Med Hyg; 1976 May; 25(3):379-83. PubMed ID: 937628 [TBL] [Abstract][Full Text] [Related]
14. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Dadashzadeh S; Vali AM; Rezaie M Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of experimental toxoplasmosis with special reference to robenidine. Bakhtari SK; Jíra J Folia Parasitol (Praha); 1988; 35(3):193-8. PubMed ID: 2974008 [TBL] [Abstract][Full Text] [Related]
16. [New pathogens and mode of action of azithromycin: Toxoplasma gondii]. Derouin F Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083 [TBL] [Abstract][Full Text] [Related]
17. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. Gillet A; Grammenos A; Compère P; Evrard B; Piel G Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395 [TBL] [Abstract][Full Text] [Related]
19. Azithromycin prophylaxis and treatment of murine toxoplasmosis. Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206 [TBL] [Abstract][Full Text] [Related]
20. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). Badiee A; Jaafari MR; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F Exp Parasitol; 2009 Apr; 121(4):362-9. PubMed ID: 19211022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]